Abstract

REVIEW ON HERBAL PLANTS

*Dipak Trambak Bhagat, Shivani Sunil Bhosale, Rushali Balasaheb Berad, Vanashri Ashok Nawale

.

Abstract

Herbal medicine remains the primary healthcare option for approximately 75–80% of the global population, particularly in developing regions, due to its cultural relevance, physiological compatibility, and minimal side effects. There has been a noticeable increase in the adoption of herbal remedies even in developed nations, with the market in the European Union and the U.S. generating billions in revenue. India, renowned for its rich biodiversity and historical tradition in herbal medicine, possesses significant growth potential in this sector but faces obstacles in fully leveraging its resources. The World Health Organization (WHO) defines herbal medicine as a component of traditional medicine, involving therapeutic approaches that existed before the advent of modern medicine. In many developed countries, herbal products such as echinacea, garlic, ginkgo, and ginseng are not only popular but also standardized and supported by clinical research. Nevertheless, India’s share of the global market remains limited, largely due to a focus on exporting raw herbs rather than processed, finished products. To enhance its international market share, India should prioritize the production of high-quality, standardized herbal formulations that meet global standards. The WHO has been instrumental in formulating guidelines to ensure the quality, safety, and effectiveness of herbal medicines, aiming for their inclusion in national healthcare systems.

Keywords: Herbal Medicine, Magnoliids, Phytochemicals.